Staff Machine Learning Research Scientist (d/f/m) | Aignostics · Teeming.ai
Aignostics
Aignostics is an AI-powered company transforming drug development and improving patient outcomes through precision medicine. They offer a range of products including Foundation Models and the Atlas H&E-TME profiling application, supported by custom services for target and biomarker discovery, translational research, and digital diagnostics. The company emphasizes its deep biomedical expertise, advanced machine learning capabilities, and collaborations with academic institutions. Aignostics, a spin-off from Charité Berlin, has offices in Berlin and New York, and is certified with ISO 13485 and 27001, with a GCP-ready clinical trial platform. They have raised $55 million in funding and employ over 120 people.
Aignostics is an AI-powered company transforming drug development and improving patient outcomes through precision medicine. They offer a range of products including Foundation Models and the Atlas H&E-TME profiling application, supported by custom services for target and biomarker discovery, translational research, and digital diagnostics. The company emphasizes its deep biomedical expertise, advanced machine learning capabilities, and collaborations with academic institutions. Aignostics, a spin-off from Charité Berlin, has offices in Berlin and New York, and is certified with ISO 13485 and 27001, with a GCP-ready clinical trial platform. They have raised $55 million in funding and employ over 120 people.
Data and AnalyticsDeepTechFoodInformation TechnologySoftware
-
Stealth Startup
🇺🇸US
Lending and InvestmentsSoftware
-
Ambience Healthcare
🇺🇸US
—
$343M
Mindpeak
🇩🇪Hamburg, DE
BiotechnologyData and AnalyticsDeepTechHealthInformation TechnologySoftware
$20M
Flinn.ai
🇦🇹AT
HealthInformation TechnologySoftware
-
Company Overview
Problem Domain
Translating complex biomedical imaging data into actionable insights for precision medicine and drug development.
Founded
2018
Industry
Biotechnology
Tech Stack
Next.js
Ruby on Rails
Google Cloud
Fastly
Material UI
Funding Track Record
Seed- 2020-08-28
€5,000,000
Series A- 2022-09-15
€14,000,000
Series B- 2024-10-29
$34,000,000
Participants included Mayo Clinic, HTGF and existing investors
Investor Signal
“Includes strategic and healthcare-focused investors such as ATHOS, Mayo Clinic, Wellington Partners, Boehringer Ingelheim Venture Fund, HTGF and IBB Ventures”
Founders
What we do
Join the Team
Staff Machine Learning Research Scientist (d/f/m)
HybridBerlin, DE
Hybrid • Berlin, DE
About the Company
Aignostics is a spin-off from one of Europe's largest and most prestigious university hospitals (Charité), with employees in Berlin and New York. We have received over $50M in funding from leading investors and are a growing team of over 100 interdisciplinary professionals. We work with academic partners as well as leading global life sciences companies.
We believe that AI has the potential to revolutionize how cancer and other complex diseases are diagnosed and treated. We also believe that AI is a tool, not an identity – without access to high-quality data and a scientifically rigorous, transparent approach to model development, AI is just a buzzword.
At Aignostics, we value and celebrate diversity and inclusion and are committed to offering equal employment and promotion opportunities for all applicants and employees. We thrive through collaboration and believe the more inclusive we are, the better our work will be.
